Task order #2--registration, storage and distribution of chemicals and drugs for pre-clinical discovery evaluation and development.

Ended Awarded Last action

Contract number
HHSN26100002
Awardee
Awarding agency
Obligated
$87,046

Award facts

Contract value 74% obligated
  • $87,046.28 Current, with exercised options
  • $117,864.84 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00011 · To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30,… -$5
Funding Only Action P00010 · To DE-obligate funds from FY2020 expiring lines following NIH oalm communication 25-06 (20241105). -$6,510
Funding Only Action P00009 · To DE-obligate funds from FY2020 expiring lines in accordance with NIH oalm -$5,753
Funding Only Action P00008 · To DE-obligate funds from FY2019 expiring lines in accordance with NIH oalm communication 23-18 -$6,350
Funding Only Action P00007 -$11,504
Funding Only Action P00006 -$7,888
Other Administrative Action P00005 $0
Exercise an Option P00004 $31,879
Exercise an Option P00003 $31,514
Exercise an Option P00002 $31,161
Exercise an Option 1 $0
Original award $30,503
Show all 12

About this award

Written by GovTribe AI ·

The National Cancer Institute (NCI) awarded this delivery order contract to Fisher Bioservices Inc., Clinical Trials Division (a subsidiary of Thermo Electron Corporation) on June 1, 2017, for the registration, storage, and distribution of chemicals and drugs for preclinical discovery evaluation and development. The contract, valued at $117,864.84 with a firm fixed price structure, was performed at the contractor's facility in Rockville, Maryland, and carried an ultimate completion date of November 29, 2024. This award carried no small business set-aside designation and represents a task order under a larger indefinite delivery contract vehicle, consistent with the NCI's ongoing need for specialized biorepository and scientific support services.

Fisher Bioservices has maintained an established relationship with the National Institutes of Health and its component agencies since 2001, providing comprehensive repository services including storage, maintenance, and distribution of biological specimens, pharmaceuticals, and research compounds. The delivery order supports the NCI's preclinical research infrastructure by ensuring proper handling and availability of chemical and drug inventories critical to cancer research initiatives. The contract's administrative de-obligation of unexpended fiscal year 2021 funding in preparation for the September 30, 2026 period closing reflects standard federal financial stewardship procedures under 31 U.S.C. Section 1552(a).

Quick answers

Who was awarded contract HHSN26100002?

HHSN26100002 was awarded to Fisher Bioservices Inc. by National Cancer Institute (National Institutes of Health) on June 1, 2017.

How much is contract HHSN26100002 worth?

The government has obligated $87,046 on HHSN26100002. Its potential value, with all options, is $117,865.

Is contract HHSN26100002 an order under another contract?

Yes. HHSN26100002 is a delivery order under HHSN261201600006I, an indefinite delivery contract.

Was contract HHSN26100002 competed?

The extent of competition for HHSN26100002 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login